4[4]Roumeguere T, Wespes E, Carpentier Y, et al. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk [J]. Eur Urol, 2003, 44(3): 355.
5[5]Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: how common and should we treat[J]?J Urol, 2003,170(2 Pt 2): S46.
6[6]Manecke R G, Mulhall J P. Trends in clinical practice:medical treatment of erectile dysfunction [J]. Ann Med,1999,31:388.
7[7]Moneland R B, Nakane M, Hsieh A, et al. Prospective for pharmacotherapy of male erectile dysfunction [J]. Curr Opin CPNS Invest Drug, 2000,2(3): 283.
8[8]Fulgham P F, Cochram J S, Denman J L, et al.Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting [J]. J Urol,1998,160(6): 2 041.
9[9]Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE- 5 inhibitors sildenafil,vardenafil and tadalafil - review of the literature [J]. Eur J Med Res, 2002, 7(10): 435.
10[10]Morales A, Gingell C, Collins M, et al. Clinical safety of oral sildenafil citrate (VIAGRA) in treatment of erectile dysfunction [J]. Int J Impot Res, 1998,10(2): 69.
